3 allergy breakthroughs from the biggest conference of the year

Hi,

Last week, over 10,000 allergists and researchers gathered in Philadelphia for the AAAAI 2026 Annual Meeting — the largest allergy science conference in the world.

1. Precision Medicine Is Replacing the Guessing Game

The conference theme was clear: the era of trial-and-error allergy treatment is ending. Researchers presented advances in AI-driven risk stratification and biomarker testing to predict which patients will respond best to specific treatments.

What this means for you: This is exactly how HeyAllergy already works. We order comprehensive allergy blood testing to identify your specific triggers, then build a personalized treatment plan including custom-mixed HeyPak® drops based on your results.

2. New Drugs for Tough-to-Treat Conditions

• Dupilumab showed strong results for allergic fungal rhinosinusitis — chronic sinus inflammation caused by mold allergy

• Bezuclastinib demonstrated efficacy for systemic mastocytosis, where mast cells accumulate in organs

• Multi-allergen immunotherapy research showed that combining treatments for patients allergic to multiple foods is becoming more practical

3. Climate Change Is Making Allergies Measurably Worse

Multiple sessions showed pollen seasons starting earlier and lasting longer, with higher peak concentrations, for over a decade. If your allergies feel worse every year, they probably are.

What this means for you: Treating symptoms with OTC pills isn’t enough when exposure is increasing. Immunotherapy addresses the root cause by training your immune system to tolerate allergens.

Want Precision Allergy Care Now?

HeyAllergy offers board-certified allergist consultations via telemedicine, comprehensive blood testing, and personalized HeyPak® allergy drops — all from home. No waitlist. Available in CA, FL, NY, TX, IL, NV, and PA.

Stay curious,

The HeyAllergy Team

Dr. Krikor Manoukian, MD, FAAAAI, FACAAI — Medical Director